T he development of immunity to pathogens is provided by the specialized effector functions of Th1 and Th2 cells, which develop under the influence of polarizing cytokines (IL-12/IFN-␥ and IL-4, respectively) that can antagonize the other's development. Recently, a third subset known as Th17 cells has become the focus of intense investigation (1) (2) (3) . Because the original report identifying them as the main effector cells of IL-23-induced experimental autoimmune encephalomyelitis (EAE) 3 (4), Th17 cells have been implicated in cancer (5, 6) , autoimmune disease (7) (8) (9) , and infection (10 -12) . Therefore, Th17 cells are an important arm of adaptive immunity and it is essential that the factors that regulate their development/maintenance be elucidated. IFN-␥ and the IFN-␥-inducible transcription factor T-bet are important for CD4 ϩ Th1 lineage commitment and stability (13) . In addition, IFN-␥ and T-bet may inhibit Th17 differentiation (14 -16) . Recently, it was reported that CD8 ϩ T cells from mutant mice lacking both T-bet and Eomes (a paralogue of T-bet) developed a potent Th17 response to infection (17) . However, Eomes expression is limited to activated CD8 ϩ T cells and is not expressed in CD4 ϩ T cells (18) . Further, it has been difficult to ascertain the separate effects of T-bet and IFN-␥ in CD4 ϩ Th17 responses due to the positive feedback loop between IFN-␥ and T-bet (i.e., the effects of IFN-␥-deficiency may be secondary to a lack of T-bet induction) (19) . To investigate the role of T-bet in the development of CD4 ϩ Th17 cells, we used a murine model of parasitic infection in which T-bet-deficient (Tbx21 Ϫ/Ϫ ) mice were infected with the intracellular pathogen T. cruzi, the causative agent of Chagas disease in humans. We report that infection of Tbx21 Ϫ/Ϫ mice with T. cruzi generated a robust Th17 response, including an increase in IL-17-producing CD8 ϩ T cells. Surprisingly, Th17 responses developed despite substantial IFN-␥ production by CD4 ϩ T cells. Furthermore, IFN-␥ did not prevent the recruitment of neutrophils observed in infected Tbx21 Ϫ/Ϫ mice. Adoptive transfer of T cells from infected Tbx21 Ϫ/Ϫ mice into Rag-2 Ϫ/Ϫ mice (Tbx21 ϩ/ϩ ) revealed that CD4 ϩ Th17 cells, in contrast to their CD8 ϩ T cell counterparts, maintained their IL-17-producing phenotype, including CD4
ϩ T cells capable of coexpressing IFN-␥ and IL-17. Importantly, adoptive transfer experiments using T cells from naive Tbx21 Ϫ/Ϫ mice demonstrated that Th17 differentiation was regulated by T-bet in a T cell-intrinsic manner and suggests that altered APC functions that may be present in Tbx21 Ϫ/Ϫ mice are not required for development of T. cruzi-specific Th17 responses in vivo. In summary, these data demonstrate that T-bet plays a critical role in regulating the development of T. cruzi-specific Th17 responses in vivo, and does so in a T cell intrinsic manner.
Materials and Methods

Mice and infections
Age and sex-matched C57BL/6, Tbx21 Ϫ/Ϫ (Tbx21, originally from Dr. Laurie Glimcher), Rag-2 Ϫ/Ϫ mice, and OT-2 TCR transgenic mice were obtained from The Jackson Laboratory and used between 6 and 8 wk of age. Mice were housed in an Association for Assessment and Accreditation of Laboratory Animal Care-accredited facility under pathogen-free conditions and procedures conducted according to an Institutional Animal Care and Use Committee-approved protocol and U.S. Department of Agriculture guidelines. For infections, 1 million T. cruzi trypomastigotes (CL strain) were injected i.p.
Ex vivo recall responses to T. cruzi
Spleen cells from T. cruzi-infected mice (day ϩ9 postinfection) were cultured in complete RPMI 1640 with low-endotoxin/azide-free anti-CD3 Ab (2C11, 0.5 g/ml, Biolegend) or T. cruzi lysate (TcL 5-10 g/ml, Ͻ0.5 EU/ml). Supernatants were collected after 24 h and IFN-␥ and IL-17 proteins measured by ELISA (Biolegend). In some cases, low-endotoxin/ azide-free-purified anti-CD4/isotype control Ab (Biolegend) was added to cultures. For intracellular cytokine staining (ICS), spleen cells were cultured on plate-bound anti-CD3 for 6 h and monensin added for the final 4 h. Cells were prepared for ICS by preincubation with purified anti-CD16/32 (Fc block), followed by surface labeling of cells with anti-CD4 or antiCD8a Abs, fixation with 4% paraformaldehyde, permeabilization, then labeling permeabilized cells with anti-IFN-␥ and anti-IL-17 Abs (Biolegend). Samples were analyzed on an FC500 instrument capable of five-color FACS (Beckman Coulter). 
Adoptive transfer into
In vivo priming assay
In some experiments, naive CD4 ϩ T cells were purified from pooled spleen/lymph nodes of OT-2 TCR transgenic mice using CD4 ϩ T cell isolation kits and negative selection (Miltenyi Biotec). CD4 ϩ T cells were labeled with CFSE, and 5-10 million T cells were injected i.v. into C57BL/6 and Tbx21 Ϫ/Ϫ mice previously infected with T. cruzi (day ϩ2 p.i.). Twenty-four hours posttransfer, infected mice were immunized i.p. with 200 g of OVA protein emulsified in mineral oil. Infected mice were euthanized day ϩ6 p.i., and spleen cells restimulated for 6 h in the presence of monensin as described above. Intracellular cytokine expression in CFSE ϩ T cells was measured by FACS.
Detection of Gr-1 ϩ cells in infected mice
At various times postinfection, venous blood was collected from individual mice and red cells were removed with lysis buffer (Biolegend). Peripheral blood leukocytes were prepared for FACS by preincubation with purified anti-CD16/32, then stained with Abs to Gr-1 (Ly6G/C), Ly6G, CD11b, as well as CD4/CD8 expression (T cell subsets) using fluorescent Abs (Biolegend). In some experiments, the number of Gr-1 ϩ /Ly6G cells in the spleen was also determined.
Statistical analysis
One-way ANOVA, two-tailed tests, as well as Tukey-Kramer multiple comparsion posttests were performed using GraphPad InStat version 3.0a for Macintosh (GraphPad Software). A p value of Ͻ 0.05 was considered significant.
Results
Concomitant production of IFN-␥ and IL-17 in
One of the more recognizable roles of T-bet is to promote IFN-␥ production and Type I immunity to intracellular pathogens. Evidence suggests that T-bet and/or IFN-␥ may also negatively regulate the development of CD4 ϩ Th17 cells. However, it has been difficult to separate the individual contributions of IFN-␥ and T-bet as they form a positive feedback loop. Nevertheless, we wished to determine the role of T-bet in CD4 ϩ T cell responses to the intracellular parasite T. cruzi. C57BL/6 and Tbx21 Ϫ/Ϫ mice were infected with T. cruzi trypomastigotes i.p., and splenocytes harvested from euthanized mice day ϩ9 p.i. Day ϩ9 p.i. was chosen because this is when we first detect T. cruzi-specific CD8 ϩ T cells in the blood of infected mice using MHC tetramers. Cells were restimulated in vitro with anti-CD3 or soluble T. cruzi lysate. Surprisingly, T cells from T. cruzi-infected Tbx21 Ϫ/Ϫ mice produced as much IFN-␥ as T cells from infected C57BL/6 mice after anti-CD3 stimulation (Fig. 1a, 308 vs 319 ng/ml). This was also observed using Ag-specific stimulation with T. cruzi lysate (Fig. 1a) , demonstrating that T-bet was dispensable for the differentiation of IFN-␥-producing, T. cruzi-specific CD4 ϩ T cells. To fully characterize the cytokine response of T cells from infected Tbx21 Ϫ/Ϫ mice, we tested culture supernatants for IL-17 and IL-4, which are signature cytokines of Th17 and Th2 immunity, respectively. In contrast to infection of Tbx21 Ϫ/Ϫ mice with other pathogens (20 -22) , we failed to detect significant increases in IL-4 or IL-10 (data not shown). However, T cells from infected Tbx21 Ϫ/Ϫ mice produced copious amounts of IL-17 concomitant with IFN-␥, and this was observed with anti-CD3 (Fig. 1b, 26 ng/ml; ‫,ءء‬ p ϭ 0.01) as well as Ag-specific stimulation using T. cruzi lysate. (3 ng/ml; Fig. 1b ; ‫,ء‬ p ϭ 0.03). Although naive T cells produced modest amounts of IL-17 with anti-CD3 (Fig. 1b, 3 .4 ng/ml), IL-17 production was not detected in T cells from infected C57BL/6 mice. To confirm the contribution of CD4 ϩ T cells to Ag-specific responses induced by T. cruzi lysate, anti-CD4 Ab was added to cultures. The production of IL-17 by T cells ex vivo (Fig. 1c, 0 .85 ng/ml), and in response to T. cruzi lysate (Fig. 1c, 1 .765 ng/ml), were almost completely inhibited by addition of anti-CD4 Ab (Fig. 1c , p Ͻ 0.01). Because we detected both IFN-␥ and IL-17 in bulk cultures, we next performed intracellular FACS analysis to measure IFN-␥ and IL-17 production at the single-cell level. As shown in Fig. 1d , the number of IFN-␥-producing CD4 ϩ T cells was equivalent between infected C57BL/6 and Tbx21 Ϫ/Ϫ mice ( ϩ T cells, we observed an increase in the number of IL-17-producing CD8 ϩ T cells in infected Tbx21 Ϫ/Ϫ mice (Fig. 1d, 4 .5% for Tbx21 Ϫ/Ϫ vs 0.8% for C57BL/6 mice). Due to experiment-to-experiment variability in the response of CD8 ϩ T cells, the increase in IL-17-producing CD8 ϩ T cells was significant ( p ϭ 0.03) but not nearly as significant as that for CD4 ϩ Th17 cells. We suspect that Eomes expression in CD8 ϩ T cells contributes to the lower, variable numbers of IL-17-producing cells.
Physiological effects of IL-17 prevail in Tbx21
Ϫ/Ϫ mice infected with T. cruzi
The results of Fig. 1 were somewhat unexpected because, in contrast to that reported for CD8 ϩ T cells (17, 18) , CD4 ϩ T cells from Tbx21 Ϫ/Ϫ mice are typically defective in their ability to produce IFN-␥ (20 -23). However, we observed normal Th1 responses in Tbx21 Ϫ/Ϫ mice infected with T. cruzi, and the IFN-␥ was not sufficient to inhibit Th17 development. However, it was possible that Th17 effector functions could still be antagonized by IFN-␥. Because recruitment of neutrophils is a hallmark feature of Th17 responses, we next determined whether neutrophilia was evident in infected Tbx21 Ϫ/Ϫ mice. To test this, blood was collected from infected mice days ϩ9 and ϩ 5 p.i., and PBL were analyzed for expression of Gr-1. As shown in Fig. 2a , there was a significant increase in the frequency of Gr-1 ϩ cells in the blood of infected C57BL/6 and Tbx21 Ϫ/Ϫ mice day ϩ9 p.i. However, there was a statistically significant higher number of Gr-1 ϩ cells in Tbx21
mice relative to C57BL/6 mice ( p ϭ 0.005). Blood collected from mice day ϩ15 p.i. revealed that while the number of Gr-1 ϩ cells in C57BL/6 mice reached a plateau, the number of Gr-1 ϩ cells continued to increase in Tbx21 Ϫ/Ϫ mice (Fig. 2a , p ϭ 0.0008). Because both mononuclear and polymorphonuclear granulocytes can react with anti-Gr-1 Ab (Ly6G/C), we wanted to confirm that the increase in Gr-1 ϩ cells in Tbx21 Ϫ/Ϫ mice reflected an increase in polymorphonuclear neutrophils. To do this, we repeated our studies using anti-Ly6G, which binds only to granulocytic neutrophils. As shown in Fig. 2b , only Tbx21 Ϫ/Ϫ mice exhibited an increase in Ly6G ϩ cells. Of note, the baseline level of Gr-1 ϩ granulocytes in peripheral blood of naive mice was identical for C57BL/6 and Tbx21 Ϫ/Ϫ mice, which is not surprising because these are uninfected mice and T-bet is typically not detected in naive T cells. These data show that despite normal levels of IFN-␥ production in infected Tbx21 Ϫ/Ϫ mice, it is unable to antagonize Th17 responses or the accompanying neutrophilia.
The phenotype of IL-17-secreting CD4
ϩ T cells from infected Tbx21 Ϫ/Ϫ mice is stable
In Fig. 1 , we observed a significant proportion of CD4 ϩ T cells (and to a lesser degree CD8 ϩ T cells) from infected Tbx21 Ϫ/Ϫ mice that produced both IL-17 and IFN-␥ (Fig. 1d) . We reasoned that these cells represented an early precursor that had not fully committed to either the Th1 or Th17 lineage. Therefore we predicted that if these T cells were rechallenged in a wild-type environment with Tbx21 ϩ/ϩ APC, it would further skew CD4 ϩ T cell responses toward a Th1 response. This hypothesis was based on the supposition that APC present in Tbx21 Ϫ/Ϫ mice may produce factors that favor the differentiation of IL-17-secreting cells. To test this hypothesis, we purified Thy1.2 ϩ T cells from C57BL/6 and Tbx21 Ϫ/Ϫ donor mice that had been previously infected with T. cruzi (Day ϩ9 p.i.). T cells were then transferred into naive Rag-2 Ϫ/Ϫ recipient mice, which were subsequently infected with T. cruzi. Day ϩ9 p.i., spleen cells were isolated and T cell cytokine production determined by intracellular cytokine staining and FACS. Contrary to our expectations, the pattern of cytokine production for CD4 ϩ T cells in Rag-2 Ϫ/Ϫ mice that received T cells from infected Tbx21 Ϫ/Ϫ donors was remarkably similar to that observed in infected Tbx21 Ϫ/Ϫ mice, including those cells capable of secreting both IL-17 and IFN-␥ (Fig. 3a) . We noted a decrease in the number of single-positive IFN-␥ ϩ CD4 ϩ T cells from C57BL/6 donors after secondary challenge in Rag-2 Ϫ/Ϫ mice (Fig.  3a, 24 vs 12%) . However, the average numbers of IFN-␥ ϩ /IL-17 ϩ and IL-17 ϩ T cells pre-and posttransfer into Rag-2 Ϫ/Ϫ mice were remarkably comparable (statistically not significant). Furthermore, even though the FACS data suggest fewer IFN-␥ ϩ cells derived from C57BL/6 donors during secondary challenge, ELISA data showed no statistical difference in anti-CD3-induced IFN-␥ production between wild-type and Tbx21 Ϫ/Ϫ cells in Rag-2 Ϫ/Ϫ mice posttransfer (Fig. 3b, 102 vs 116 ng/ml, NS). To confirm the Ag specificity of the Th17 response and determine whether the difference in the number of IFN-␥ ϩ CD4 ϩ T cells was biologically relevant, spleen cells were cultured with T. cruzi lysate and supernatants tested for IFN-␥ and IL-17 protein by ELISA. As shown in Fig. 3b , IFN-␥ secretion was comparable between Rag-2 Ϫ/Ϫ mice receiving C57BL/6 or Tbx21 Ϫ/Ϫ T cells (Fig. 3b, 12 vs 7 ng/ml, NS). Based on the ELISA data, there appears to be no significant difference in the number of IFN-␥-producing T cells derived from C57BL/6 donors. Nevertheless, Rag-2 Ϫ/Ϫ mice that received Tbx21
Ϫ/Ϫ T cells demonstrated significant IL-17 production (Fig.  3c, 0 .002 vs 0.9 ng/ml, ‫,ء‬ p ϭ 0.01 for T. cruzi lysate stimulation; ‫,ءءء‬ p ϭ 0.003 for anti-CD3 stimulation). Therefore, IL-17-secreting T cells from infected Tbx21 Ϫ/Ϫ mice appear to be stable and their further differentiation is not influenced by cytokines present in Rag-2 Ϫ/Ϫ (Tbx21 ϩ/ϩ ) mice. In contrast to CD4
ϩ T cells, we observed that the number of IL-17-producing CD8 ϩ T cells was not maintained after transfer into Rag-2 Ϫ/Ϫ mice and subsequent infection (Fig. 3d, 4 .5 vs 0.7%). However, 
Th17 cells from infected Tbx21 Ϫ/Ϫ mice are resistant to the inhibitory effects of IL-2
Recently, it was shown that IL-2 and Stat-5 signaling are inhibitory to Th17 differentiation (24) . Because CD4 ϩ T cells from infected Tbx21 Ϫ/Ϫ mice displayed both IL-17 ϩ and IL-17 ϩ /IFN-␥ ϩ phenotypes, we wanted to determine whether these cells were susceptible to the inhibitory effects of IL-2. Therefore T cells were restimulated in the presence of exogenous IL-2. As shown in Fig. 4a , IL-2 had no effect on the pattern of IL-17 expression in CD4 ϩ T cells, including those cells capable of making both IFN-␥ and IL-17. Furthermore, analysis of supernatants after 3 days culture confirmed that IL-2 had no effect on IL-17 production induced by either anti-CD3 or T. cruzi Ags (T. cruzi lysate) (Fig. 4b) . However, it was possible that the failure of IL-2 to inhibit IL-17 production could be secondary to a lack of CD25 expression, the high affinity IL-2 receptor. Therefore we examined T cells from infected mice for CD25 expression by FACS. Surprisingly, T cells from infected Tbx21 Ϫ/Ϫ mice exhibited a hyperactivated phenotype (Fig. 4c) , as the percentage of CD25 ϩ T cells and mean fluorescence intensity of CD25 expression were significantly elevated in Tbx21 Ϫ/Ϫ mice. This is remarkably similar to that reported for CD8 ϩ T cells in mice doubly deficient for Eomes and T-bet (17). We also observed that CD4 ϩ T cells from Tbx21 Ϫ/Ϫ mice expressed higher levels of IL-2, consistent with previous reports (25) . To confirm that the concentration of IL-2 used (10 ng/ml) was able to suppress Th17 development in naive T cells, we tested CD4 ϩ T cells that had been cultured under Th17-polarizing conditions for 3 days in the presence of IL-2 (Fig. 4d) . Clearly, addition of IL-2 was able to suppress the development of Th17 cells in vitro as previously reported (24) . In summary, the data in Figs. 3 
and 4 demonstrate that Th17 cells generated in infected Tbx21
Ϫ/Ϫ mice are stable, in that the pattern of IL-17 production is not affected by rechallenge with wild-type APC or IL-2.
T-bet regulates Th17 development in a T cell-intrinsic manner
In contrast to experiments that examined the maintenance of IL-17-secreting CD4 ϩ T cells from infected mice (Figs. 3 and 4) , there was a distinct possibility that the development of Th17 cells in Tbx21 Ϫ/Ϫ mice could be secondary to Ag-presentation functions that are unique to Tbx21 Ϫ/Ϫ mice, including altered cytokine production by APC. To determine whether the development of Th17 cells in infected Tbx21 Ϫ/Ϫ mice was controlled by T-bet in a T cell or APC intrinsic manner, we first examined the differentiation of T cells from naive Tbx21 Ϫ/Ϫ mice in a wild-type, T-bet-sufficient environment. Thy1.2 ϩ T cells were purified from naive C57BL/6 or Tbx21 Ϫ/Ϫ donor mice and transferred into naive Rag-2 Ϫ/Ϫ recipients (Tbx21 ϩ/ϩ ), which were subsequently infected with T. cruzi 24 h posttransfer. Day ϩ9 p.i., spleen cells were isolated and FACS analysis performed to determine the cytokine-producing phenotype of Thy1.2 ϩ donor T cells. Remarkably, CD4 ϩ T cells from naive Tbx21 Ϫ/Ϫ mice differentiated into IL-17-secreting T cells in Rag-2 Ϫ/Ϫ mice recipients (Fig. 5a, right) , with a pattern of cytokine production that was strikingly similar to day ϩ9-infected Tbx21 Ϫ/Ϫ mice (Fig. 1c) including T cells capable of producing IL-17, IFN-␥, and both IL-17 and IFN-␥. Although there was a statistically significant decrease in the number of single-positive IFN-␥ ϩ T cells from Tbx21 Ϫ/Ϫ mice (Fig. 5a, 21 vs 8 .5%, p ϭ 0.004), there was no statistical significance in the total number of IFN-␥ ϩ T cells (Fig. 5a, 21 vs 14% ). In contrast, the difference in the number of IL-17-producing T cells in Tbx21 Ϫ/Ϫ mice was extremely significant ( p Ͻ 0.0001). We also observed an increase in the number of IL-17-producing CD8 ϩ T cells after transfer of Thy1.2 ϩ T cells from naive Tbx21 Ϫ/Ϫ donors into Rag-2 Ϫ/Ϫ mice (Fig. 5d, 1.5 vs 0.1%, p Ͻ 0.0001) , in addition to equivalent numbers of IFN-␥ ϩ CD8 ϩ T cells (Fig. 5d, NS) . However, in sharp contrast to the number of IL-17-producing CD8 ϩ T cells obtained with primary infection of Tbx21 Ϫ/Ϫ mice (Fig. 1) , the number of IL-17 ϩ CD8 ϩ T cells was significantly lower during primary challenge of Rag-2 Ϫ/Ϫ mice (Fig. 5d ), yet higher than with secondary challenge of Rag-2 Ϫ/Ϫ mice (Fig. 3d) . These data suggest that infection of Rag-2 Ϫ/Ϫ mice may pose selective pressure on CD8 ϩ T cells to express IFN-␥. As shown in Fig. 5b , T cells from Rag-2 Ϫ/Ϫ recipients produced IL-17 in an Ag-specific manner, and this response was blocked by anti-CD4 ( Fig. 5b; p ϭ 0.007) . Finally, to determine whether the neutrophilia observed in infected Tbx21 Ϫ/Ϫ mice was recapitulated in Rag-2 Ϫ/Ϫ mice, we examined blood from infected Rag-2 Ϫ/Ϫ recipient mice for Gr-1 expression (day ϩ9 p.i.). Consistent with the results obtained from day ϩ9-infected Tbx21 Ϫ/Ϫ mice, there was a significant increase in the number of Gr-1 ϩ cells in the blood of Rag-2 Ϫ/Ϫ mice that received donor Tbx21 Ϫ/Ϫ T cells (Fig. 5c) . Thus, the development of T.
cruzi-specific Th17 cells in infected Tbx21
Ϫ/Ϫ mice is controlled by T-bet in a T cell intrinsic manner.
Naive T-bet-sufficient T cells do not exhibit increased Th17 differentiation in infected Tbx21
Ϫ/Ϫ mice
The data presented in Fig. 5 show that the development of Th17 cells in Tbx21 Ϫ/Ϫ mice infected with T. cruzi is regulated in a T cell intrinsic manner. To further address a possible role for altered APC functions in the development of Th17 cells in Tbx21 Ϫ/Ϫ mice, we used an in vivo Ag presentation assay using CD4 ϩ T cells from OT-2 transgenic mice specific for OVA. CD4 ϩ T cells from naive OT-2 mice were purified, CFSE-labeled, and transferred into C57BL/6 and Tbx21 Ϫ/Ϫ mice previously infected with T. cruzi (day ϩ2 p.i.). After 24 h (day ϩ3 p.i.), recipient mice were subsequently immunized with OVA i.p. To avoid the complication of Mycobacterium cell wall components and their possible effects on TLR stimulation and thus T cell cytokine production in vivo, we did not use CFA as an adjuvant for immunizations. Infected/ immunized mice were euthanized 3 days postimmunization (day ϩ6 postinfection). Spleen and lymph node cells were harvested from mice and restimulated in vitro for analysis of IFN-␥/IL-17 production. FACS analysis revealed that the number of IFN-␥-producing OT-2 T cells was comparable in infected C57BL/6 and Tbx21 Ϫ/Ϫ recipients (Fig. 6) . Importantly, there was no significant difference in the number of IL-17-secreting OT-2 T cells. CFSE analysis confirmed that OT-2 T cells underwent OVA-induced proliferation in vivo (data not shown). Therefore, these data confirm that the development of T. cruzi-specific CD4 ϩ Th17 cells is regulated by T-bet in a T cell intrinsic manner, and that APC functions unique to Tbx21 Ϫ/Ϫ mice are not required for Th17 differentiation in vivo.
Discussion
Since the original discovery of Th17 cells as the main effector cells of EAE (4), there has been a significant increase in the number of reports focused on various aspects of Th17 biology, including the molecular factors that regulate Th17 development (1-3) . For instance, the nuclear orphan receptor ROR␥t is expressed in Th17 Ϫ/Ϫ mice. CD4 ϩ T cells from naive OT-2 mice were purified and labeled with CFSE for identification in vivo. Five million CFSE ϩ OT-2 T cells were subsequently transferred into either C57BL/6 or Tbx21 Ϫ/Ϫ mice previously infected with T. cruzi (day ϩ2 p.i.). Twentyfour hours posttransfer, infected mice were immunized with OVA emulsified in mineral oil (day ϩ3 p.i.). Day ϩ6 p.i., infected recipient mice were euthanized, and spleen cells harvested and restimulated as described in Fig. 1c . The number of IFN-␥ or IL-17-producing OT-2 T cells was determined by FACS, gating on the CFSE ϩ population.
cells and is necessary for Th17 development (26) . In contrast, Tbet and IFN-␥ have been implicated in the negative regulation of Th17 development (15, 16, (27) (28) (29) . However, it has been difficult to ascertain the separate effects of IFN-␥ and T-bet on CD4 ϩ Th17 cell development due to the positive feedback loop that exists between them (19) . Therefore, the effects of IFN-␥ deficiency may be secondary to a lack of T-bet induction. Further, the relationship between IFN-␥, T-bet, and CD4
ϩ Th17 responses to infection is not clear. Therefore, the goal of the present study was to investigate the role of T-bet in differentiation of CD4 ϩ T cells during infection with the protozoan parasite T. cruzi, the causative agent of human Chagas disease. We report that, in contrast to wild-type mice, infection of Tbx21 Ϫ/Ϫ mice with T. cruzi generated a robust, Ag-specific Th17 response. However, the Th17 response did not develop at the expense of Th1 responses, as IFN-␥ production and the number of IFN-␥-producing T cells were equivalent to wildtype mice. We observed a similar response in CD8 ϩ T cells derived from infected Tbx21 Ϫ/Ϫ mice, which is consistent with results reported by others (17, 30) . However, one notable exception is that IL-17 production by CD8 ϩ T cells tended to decrease upon transfer into infected Rag-2 Ϫ/Ϫ mice (see below). We noticed that despite similar numbers of IFN-␥ and IL-17-producing CD4 ϩ T cells (Fig. 1d) , IFN-␥ production tended to be higher compared with IL-17 ( Fig. 1, a and b) . We believe the apparent discrepancy is related to the kinetics of IFN-␥ and IL-17 expression. The FACS data shown in Fig. 1d represent the number of IFN-␥/IL-17-producing CD4
ϩ T cells after a 6-h restimulation in vitro. However, culture supernatants used for ELISA were collected after 18 -36 h of stimulation. The higher levels of IFN-␥ are most likely due to sustained expression of IFN-␥. Although we do not know the kinetics of IL-17 production in T cells, the levels of secreted IL-17 in our study are comparable to those reported for other studies in which Ag-specific T cells were primed in vivo (29, 31) . The difference in magnitude of IFN-␥ and IL-17 secretion is also seen with primary stimulation of T cells in vitro (16) . Nevertheless, despite high levels of IFN-␥ production, Tbx21 Ϫ/Ϫ mice displayed a potent and chronic neutrophilia, as well as increased morbidity and mortality with T. cruzi infection. Because wild-type mice (which do not develop a Th17 response) are able to control infection and remain clinically healthy despite being persistently infected, we suspect that Th17 cells are harmful during T. cruzi infection. However, infected Tbx21 Ϫ/Ϫ mice also display a severe defect in the ability to generate T. cruzi-specific CD8 ϩ T cells (submitted for publication), and this defect undoubtedly contributes to susceptibility. Although T-bet-independent IFN-␥ production has been reported for T cells, it is observed mostly in CD8 ϩ T cells due to the compensatory functions of Eomes, a transcription factor similar to T-bet whose expression is limited to CD8 ϩ T cells (17, 32) . In contrast to CD8 ϩ T cells, infection of Tbx21
mice with Leishmania, Mycobacterium, Salmonella, Listeria, HSV-2, or vaccinia virus caused significant reductions in IFN-␥-producing CD4 ϩ Th1 cells (20 -23, 33, 34) . Although T-bet-independent IFN-␥ production was reported for Listeria infection (34), IFN-␥ production by CD4 ϩ T cells was still significantly reduced in Tbx21 Ϫ/Ϫ mice (34). Although we do not yet know the compensatory mechanism(s) that drive IFN-␥ production in Tbx21 Ϫ/Ϫ mice, we suspect that unique features of T. cruzi infection (persistent, systemic) may favor normal development of IFN-␥-producing CD4
ϩ Th1 cells independent of T-bet. We hypothesize that IL-12 may drive IFN-␥ production independent of T-bet, particularly because we failed to detect any significant increase in IL-4 or IL-10 (known Th2-associated cytokines) in Tbx21 Ϫ/Ϫ mice infected with T. cruzi (data not shown). Alternatively, IL-18 may be involved, as IL-18 can drive IFN-␥ production during T. cruzi infection (35) . Nevertheless, it is the mere presence of IFN-␥ itself that is critical to our studies because the data show that even under conditions in which T-bet is not required for Th1 development, T-bet is still required to antagonize the development of CD4 ϩ Th17 cells. We were surprised that despite a normal IFN-␥ response in infected Tbx21 Ϫ/Ϫ mice it had no effect on the development of T. cruzi-specific Th17 cells (Fig. 1) , nor did it affect the sharp and sustained recruitment of neutrophils (Fig. 2) . These data suggest that T-bet regulates the development of Th17 responses to T. cruzi infection in an IFN-␥-independent manner. Interestingly, it was previously shown that BCG infection could inhibit pathogenic Th17 responses and EAE in an IFN-␥-dependent manner, although the role of T-bet was not addressed (36) . Similarly, CD8 ϩ IL-17 responses were increased in Tbx21 Ϫ/Ϫ mice, but otherwise unaffected in Ifn-␥ Ϫ/Ϫ mice in a model of allogeneic transplantation (30) . T-bet was also shown to regulate IL-17 production by heart-specific T cells in experimental autoimmune myocarditis, and the severity of disease in Tbx21 Ϫ/Ϫ mice was not duplicated by IFN-␥ deficiency (29) . Furthermore, the number of IL-17-producing T cells triggered by systemic autoimmune disease was greatly increased in Tbx21 Ϫ/Ϫ mice relative to Ifn-␥ Ϫ/Ϫ mice (37). The idea that IFN-␥ inhibits Th17 responses is not consistent with the observation that Th1 and Th17 cells can coexist under pathological conditions such as psoriasis (38) or infection with Mycobacterium (15) or T. cruzi (this report). Simultaneous production of IFN-␥ and IL-17 was also observed at the single cell level, where we identified a substantial proportion of CD4 ϩ T cells capable of secreting both IFN-␥ and IL-17. This mixed CD4 ϩ response was also reported with experimental autoimmune disease (26, 37) . CD8
ϩ T cells capable of making both IFN-␥ and IL-17 have also been observed in vivo with allogeneic responses (30) . It is noteworthy that IL-17 ϩ /IFN-␥ ϩ cells are not always a prominent feature of experimental approaches used to study Th17 differentiation. Although we do not yet understand the basis for this, we speculate that in vitro culture under polarizing conditions or CD4 ϩ T cell responses to physiological stimuli may play a role. Despite reports that IFN-␥ and T-bet can suppress the Th17 lineage, the effects of IFN-␥ on Th17 development may involve APC functions, as IFN-␥ can inhibit IL-23 production (15) . Nevertheless, we predicted that IFN-␥ ϩ /IL-17 ϩ CD4 ϩ T cells represented an intermediate that had not fully committed to the Th1 or Th17 lineage. Therefore, we hypothesized that if these cells were restimulated in a wild-type environment with wild-type APC, it would support further differentiation into the Th1 lineage. However, this was not the case as CD4 ϩ T cells making IFN-␥ and IL-17 retained their cytokine-producing phenotype during rechallenge in Rag-2 Ϫ/Ϫ mice. Furthermore, the pattern of cytokine production was not altered by culture with IL-2. This is in contrast to the effects of IL-2/Stat-5 signaling on naive T cells, which inhibit Th17 development (24) . It is noteworthy that CD4 ϩ T cells from
T. cruzi-infected Tbx21
Ϫ/Ϫ mice produced more IL-2 on a per-cell basis (data not shown). Although this observation has been previously reported (25) , the prediction would be that increased IL-2 would further suppress Th17 development. This is clearly not the case with T. cruzi infection. In stark contrast to IL-17-producing CD4 ϩ T cells, we observed that the number of IL-17-secreting CD8 ϩ T cells decreased after transfer into Rag-2 Ϫ/Ϫ mice that were challenged with T. cruzi. Although we do not know the reasons for this, we suspect that Eomes expression compensates for T-bet deficiency and drives IFN-␥ production due to the selective pressure to produce IFN-␥ in infected Rag-2 Ϫ/Ϫ mice. These data demonstrate that IL-17-secreting CD4 ϩ T cells in infected Tbx21 Ϫ/Ϫ mice represent a stable population of T cells, and are resistant to the effects of IL-2.
Because the aforementioned studies used Tbx21 Ϫ/Ϫ mice with a germline mutation in Tbx21, and because T-bet is expressed in other immune cell types including dendritic cells (39), we performed additional studies to determine whether Th17 responses to T. cruzi infection were controlled by T-bet in a T cell-intrinsic manner; alternatively, whether T cells were more susceptible to Th17 differentiation due to intrinsic differences in the APC environment of Tbx21 Ϫ/Ϫ mice. Reconstitution of Rag-2 Ϫ/Ϫ mice (Tbx21 ϩ/ϩ ) with T-bet-deficient T cells recapitulated the effect observed in Tbx21 Ϫ/Ϫ mice, with significant development of CD4 ϩ , and to a lesser extent CD8 ϩ Th17 cells. Furthermore, wild-type T cells primed in infected Tbx21 Ϫ/Ϫ mice did not show a preferential skewing toward Th17 differentiation. In summary, these data demonstrate that T-bet regulates the development of T. cruzi-specific CD4 ϩ Th17 cells in vivo in a T cell-intrinsic manner, and suggest that while under certain pathological conditions in which T-bet is dispensable for IFN-␥ production (i.e., persistent infection and/or proinflammatory cytokine production), T-bet induction is required to limit potentially harmful Th17 responses to infection.
